Crk at the quarter century mark

Perspectives in signaling and cancer

Sushil Kumar, Jorge E. Fajardo, Raymond B. Birge, Ganapathy Sriram

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The Crk adaptor protein, discovered 25 years ago as the transforming gene (v-crk) product encoded by the CT10 avian retrovirus, has made a great impact on the field of signal transduction. By encoding an oncoprotein that contained a viral gag protein fused to only SH2 and SH3 domains, v-Crk demonstrated the significance of SH2 and SH3 domains in oncogenic signaling by their virtue of binding in a sequence-specific context to organize and assemble protein networks. In more recent years, the cellular homologs of Crk (Crk II, Crk I, and CrkL) have been extensively studied, and shown to have critical functions in a wide spectrum of biological and pathological processes that include cell motility, invasion, survival, bacterial pathogenesis, and the efferocytosis of apoptotic cells. Clinically, Crk proteins are implicated in the aggressive behavior of human cancers, including adenocarcinomas of the lung, breast, and stomach, as well as in sarcomas and gliomas. Over-expression of Crk proteins in human cancers has led to a renewed interest in both their signal transduction pathways and mechanisms of up-regulation. This prospect summarizes recent developments in Crk biology, including new structural and biochemical roles for the atypical carboxyl-terminal SH3 (SH3C) domain, revelations regarding the molecular differences between Crk II and Crk L, and the significance of Crk expression in stratified human tumor samples.

Original languageEnglish (US)
Pages (from-to)819-825
Number of pages7
JournalJournal of Cellular Biochemistry
Volume115
Issue number5
DOIs
StatePublished - 2014

Fingerprint

src Homology Domains
Signal transduction
Neoplasms
Proteins
Signal Transduction
gag Gene Products
Oncogene Proteins
Biological Phenomena
Tumors
Pathologic Processes
Retroviridae
Oncogenes
Glioma
Genes
Sarcoma
Cells
Cell Movement
Stomach
Breast
Up-Regulation

Keywords

  • CANCER GENETICS
  • Crk
  • SH2 and SH3 DOMAIN
  • TYROSINE PHOSPHORYLATION

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Crk at the quarter century mark : Perspectives in signaling and cancer. / Kumar, Sushil; Fajardo, Jorge E.; Birge, Raymond B.; Sriram, Ganapathy.

In: Journal of Cellular Biochemistry, Vol. 115, No. 5, 2014, p. 819-825.

Research output: Contribution to journalArticle

Kumar, Sushil ; Fajardo, Jorge E. ; Birge, Raymond B. ; Sriram, Ganapathy. / Crk at the quarter century mark : Perspectives in signaling and cancer. In: Journal of Cellular Biochemistry. 2014 ; Vol. 115, No. 5. pp. 819-825.
@article{b340f654c75f45dbac94637cbb226683,
title = "Crk at the quarter century mark: Perspectives in signaling and cancer",
abstract = "The Crk adaptor protein, discovered 25 years ago as the transforming gene (v-crk) product encoded by the CT10 avian retrovirus, has made a great impact on the field of signal transduction. By encoding an oncoprotein that contained a viral gag protein fused to only SH2 and SH3 domains, v-Crk demonstrated the significance of SH2 and SH3 domains in oncogenic signaling by their virtue of binding in a sequence-specific context to organize and assemble protein networks. In more recent years, the cellular homologs of Crk (Crk II, Crk I, and CrkL) have been extensively studied, and shown to have critical functions in a wide spectrum of biological and pathological processes that include cell motility, invasion, survival, bacterial pathogenesis, and the efferocytosis of apoptotic cells. Clinically, Crk proteins are implicated in the aggressive behavior of human cancers, including adenocarcinomas of the lung, breast, and stomach, as well as in sarcomas and gliomas. Over-expression of Crk proteins in human cancers has led to a renewed interest in both their signal transduction pathways and mechanisms of up-regulation. This prospect summarizes recent developments in Crk biology, including new structural and biochemical roles for the atypical carboxyl-terminal SH3 (SH3C) domain, revelations regarding the molecular differences between Crk II and Crk L, and the significance of Crk expression in stratified human tumor samples.",
keywords = "CANCER GENETICS, Crk, SH2 and SH3 DOMAIN, TYROSINE PHOSPHORYLATION",
author = "Sushil Kumar and Fajardo, {Jorge E.} and Birge, {Raymond B.} and Ganapathy Sriram",
year = "2014",
doi = "10.1002/jcb.24749",
language = "English (US)",
volume = "115",
pages = "819--825",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Crk at the quarter century mark

T2 - Perspectives in signaling and cancer

AU - Kumar, Sushil

AU - Fajardo, Jorge E.

AU - Birge, Raymond B.

AU - Sriram, Ganapathy

PY - 2014

Y1 - 2014

N2 - The Crk adaptor protein, discovered 25 years ago as the transforming gene (v-crk) product encoded by the CT10 avian retrovirus, has made a great impact on the field of signal transduction. By encoding an oncoprotein that contained a viral gag protein fused to only SH2 and SH3 domains, v-Crk demonstrated the significance of SH2 and SH3 domains in oncogenic signaling by their virtue of binding in a sequence-specific context to organize and assemble protein networks. In more recent years, the cellular homologs of Crk (Crk II, Crk I, and CrkL) have been extensively studied, and shown to have critical functions in a wide spectrum of biological and pathological processes that include cell motility, invasion, survival, bacterial pathogenesis, and the efferocytosis of apoptotic cells. Clinically, Crk proteins are implicated in the aggressive behavior of human cancers, including adenocarcinomas of the lung, breast, and stomach, as well as in sarcomas and gliomas. Over-expression of Crk proteins in human cancers has led to a renewed interest in both their signal transduction pathways and mechanisms of up-regulation. This prospect summarizes recent developments in Crk biology, including new structural and biochemical roles for the atypical carboxyl-terminal SH3 (SH3C) domain, revelations regarding the molecular differences between Crk II and Crk L, and the significance of Crk expression in stratified human tumor samples.

AB - The Crk adaptor protein, discovered 25 years ago as the transforming gene (v-crk) product encoded by the CT10 avian retrovirus, has made a great impact on the field of signal transduction. By encoding an oncoprotein that contained a viral gag protein fused to only SH2 and SH3 domains, v-Crk demonstrated the significance of SH2 and SH3 domains in oncogenic signaling by their virtue of binding in a sequence-specific context to organize and assemble protein networks. In more recent years, the cellular homologs of Crk (Crk II, Crk I, and CrkL) have been extensively studied, and shown to have critical functions in a wide spectrum of biological and pathological processes that include cell motility, invasion, survival, bacterial pathogenesis, and the efferocytosis of apoptotic cells. Clinically, Crk proteins are implicated in the aggressive behavior of human cancers, including adenocarcinomas of the lung, breast, and stomach, as well as in sarcomas and gliomas. Over-expression of Crk proteins in human cancers has led to a renewed interest in both their signal transduction pathways and mechanisms of up-regulation. This prospect summarizes recent developments in Crk biology, including new structural and biochemical roles for the atypical carboxyl-terminal SH3 (SH3C) domain, revelations regarding the molecular differences between Crk II and Crk L, and the significance of Crk expression in stratified human tumor samples.

KW - CANCER GENETICS

KW - Crk

KW - SH2 and SH3 DOMAIN

KW - TYROSINE PHOSPHORYLATION

UR - http://www.scopus.com/inward/record.url?scp=84895549289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895549289&partnerID=8YFLogxK

U2 - 10.1002/jcb.24749

DO - 10.1002/jcb.24749

M3 - Article

VL - 115

SP - 819

EP - 825

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 5

ER -